{"date":"2026-06-08","count":28,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4131-2026-06-08-1738-j5r1pz","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-06-08","time":"17:38:52","subject":"公告更正本公司114年度年報部分內容","clause":"第53款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-06-08 17:38，「公告更正本公司114年度年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-06-08-1727-1y0s825","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-06-08","time":"17:27:37","subject":"公告本公司新任主辦輔導推薦證券商事宜","clause":"第44款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-06-08 17:27，「公告本公司新任主辦輔導推薦證券商事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-06-08-1711-5vl08h","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-06-08","time":"17:11:08","subject":"公告本公司訴訟及非訟代理人異動","clause":"第8款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-06-08 17:11，「公告本公司訴訟及非訟代理人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-06-08-1708-6i52ml","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-06-08","time":"17:08:21","subject":"（補充公告）本公司115年第1季財報提報董事會之會議召集通知","clause":"第31款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-06-08 17:08，「（補充公告）本公司115年第1季財報提報董事會之會議召集通知」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-06-08-1701-16xx3hr","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-06-08","time":"17:01:40","subject":"代子公司嘉文麗（福建）化妝品限公司公告累積取得或處分理財產品","clause":"第20款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-06-08 17:01，「代子公司嘉文麗（福建）化妝品限公司公告累積取得或處分理財產品」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2026-06-08-1649-1ap8fql","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2026-06-08","time":"16:49:16","subject":"公告本公司註銷收回之限制員工權利新股辦理減資變更登記完成","clause":"第36款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2026-06-08 16:49，「公告本公司註銷收回之限制員工權利新股辦理減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-06-08-1643-6rqyk5","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-06-08","time":"16:43:16","subject":"公告本公司取得有價證券","clause":"第20款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-06-08 16:43，「公告本公司取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-06-08-1640-1xvirge","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-06-08","time":"16:40:13","subject":"公告本公司董事逝世解任","clause":"第6款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-06-08 16:40，「公告本公司董事逝世解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2026-06-08-1628-tbh98m","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2026-06-08","time":"16:28:19","subject":"本公司召開線上法人說明會","clause":"第12款","fact_date":"2026-06-11","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2026-06-08 16:28，「本公司召開線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-06-08-1621-1qtp20d","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-06-08","time":"16:21:49","subject":"公告修正本公司114年度年報部分內容","clause":"第53款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-06-08 16:21，「公告修正本公司114年度年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-06-08-1612-1kxjsl","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-06-08","time":"16:12:27","subject":"(補充公告)財務主管、會計主管暨公司治理主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-06-08 16:12，「(補充公告)財務主管、會計主管暨公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-06-08-1559-1gqegjb","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-06-08","time":"15:59:14","subject":"公告本公司第三屆審計委員會","clause":"第6款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-06-08 15:59，「公告本公司第三屆審計委員會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-06-08-1558-i4i8ni","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-06-08","time":"15:58:22","subject":"公告本公司第十一屆董事長選任","clause":"第6款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-06-08 15:58，「公告本公司第十一屆董事長選任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-06-08-1557-1gdqoy4","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-06-08","time":"15:57:26","subject":"公告本公司股東會決議許可董事從事競業行為","clause":"第21款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-06-08 15:57，「公告本公司股東會決議許可董事從事競業行為」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-06-08-1556-91gxxk","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-06-08","time":"15:56:27","subject":"公告本公司董事當選名單(變動達三分之一)","clause":"第6款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-06-08 15:56，「公告本公司董事當選名單(變動達三分之一)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-06-08-1555-1jb8ii5","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-06-08","time":"15:55:09","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-06-08 15:55，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7832-2026-06-08-1534-1jb8ii5","company_id":"7832","company":"智新生技*","market":"興櫃","industry":"生技醫療","date":"2026-06-08","time":"15:34:35","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：智新生技*（7832），2026-06-08 15:34，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-06-08-1523-1udd9xf","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-06-08","time":"15:23:05","subject":"公告本公司新任法人董事指派代表人","clause":"第6款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-06-08 15:23，「公告本公司新任法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-06-08-1522-iywrok","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-06-08","time":"15:22:33","subject":"公告本公司115年股東常會補選董事一席","clause":"第6款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-06-08 15:22，「公告本公司115年股東常會補選董事一席」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-06-08-1516-1jb8ii5","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-06-08","time":"15:16:43","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-06-08 15:16，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-06-08-1506-18tokoi","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-06-08","time":"15:06:58","subject":"Telomelysin (OBP-301) 正式取得日本上市銷售許可","clause":"第53款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-06-08 15:06，「Telomelysin (OBP-301) 正式取得日本上市銷售許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-06-08-1446-1xp4un9","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-06-08","time":"14:46:31","subject":"公告本公司第三屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-06-08 14:46，「公告本公司第三屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-06-08-1446-1r2d1uw","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-06-08","time":"14:46:11","subject":"公告本公司第三屆審計委員會委員","clause":"第6款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-06-08 14:46，「公告本公司第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-06-08-1445-9769qc","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-06-08","time":"14:45:48","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-06-08 14:45，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-06-08-1445-hom644","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-06-08","time":"14:45:25","subject":"公告本公司115年股東常會決議解除新任董事競業限制案","clause":"第22款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-06-08 14:45，「公告本公司115年股東常會決議解除新任董事競業限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2026-06-08-1445-13e076x","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2026-06-08","time":"14:45:03","subject":"公告本公司現金股利配息基準日","clause":"第14款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2026-06-08 14:45，「公告本公司現金股利配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-06-08-1444-1hvkc3c","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-06-08","time":"14:44:09","subject":"公告本公司115年股東常會全面改選董事","clause":"第6款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-06-08 14:44，「公告本公司115年股東常會全面改選董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2026-06-08-1442-1jb8ii5","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-06-08","time":"14:42:54","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-08","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2026-06-08 14:42，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}